![James Loerop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Loerop
Corporate Officer/Principal bei
ACLARIS THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 30.06.2026
Profil
Mr. James Loerop is a Chief Business Officer at Aclaris Therapeutics, Inc. Mr. Loerop was previously employed as an EVP-Business Development & Strategic Planning by Anika Therapeutics, Inc., a Chief Corporate Development Officer by Lupin Pharmaceuticals, Inc., a SVP-Global Business Development by Alexion Pharmaceuticals, Inc., a VP-North America Business Development by GlaxoSmithKline LLC, and a SVP-Global Corporate Development by Stiefel Laboratories, Inc. He received his undergraduate degree from Western Michigan University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.04.2026 | 192 260 ( 0,14 % ) | 1 Mio $ | 30.06.2026 |
Aktive Positionen von James Loerop
| Unternehmen | Position | Beginn |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Corporate Officer/Principal | 31.01.2022 |
Ehemalige bekannte Positionen von James Loerop
| Unternehmen | Position | Ende |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2022 |
Lupin Pharmaceuticals, Inc.
 Lupin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes generic formulations, biotechnology products & APIs | Corporate Officer/Principal | 01.07.2019 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.09.2017 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | 01.04.2015 |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.12.2010 |
Ausbildung von James Loerop
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Anika Therapeutics, Inc.
 Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
Western Michigan University
 Western Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes generic formulations, biotechnology products & APIs | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
